StockData
Anixa Biosciences Inc logo

Anixa Biosciences Inc (ANIX) stock

ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 5/30
$2.44−0.16 (-6.15%)

Close on Nov 20, 2026Market cap $84.82MP/E –Yield –

Anixa Biosciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Anixa Biosciences's free cash flow for the twelve months ending Oct 31, 2020 was -$6.19M. For fiscal 2020 it was -$6.19M. The highest annual figure on record is $1.31M in fiscal 2015.

Annual free cash flow

PeriodPeriod endValueChange
FY2020Oct 31, 2020-$6.19M–
FY2019Oct 31, 2019-$4.92M–
FY2018Oct 31, 2018-$4.31M–
FY2017Oct 31, 2017-$3.83M–
FY2016Oct 31, 2016-$3.53M-369.6%
FY2015Oct 31, 2015$1.31M–
FY2014Oct 31, 2014-$2.39M–
FY2012Oct 31, 2012-$3.14M–
FY2011Oct 31, 2011-$725.03K–
FY2010Oct 31, 2010-$2.41M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2020CQ3 2020Oct 31, 2020-$1.41M–
Q3 FY2020CQ2 2020Jul 31, 2020-$1.29M–
Q2 FY2020CQ1 2020Apr 30, 2020-$1.56M–
Q1 FY2020CQ4 2019Jan 31, 2020-$1.93M–
Q4 FY2019CQ3 2019Oct 31, 2019-$1.34M–
Q3 FY2019CQ2 2019Jul 31, 2019-$640.10K–
Q4 FY2018CQ3 2018Oct 31, 2018-$1.03M–
Q3 FY2018CQ2 2018Jul 31, 2018-$1.19M–
Q2 FY2018CQ1 2018Apr 30, 2018-$751.78K–
Q1 FY2018CQ4 2017Jan 31, 2018-$1.34M–
Q4 FY2017CQ3 2017Oct 31, 2017-$752.59K–
Q3 FY2017CQ2 2017Jul 31, 2017-$1.25M–
Q2 FY2017CQ1 2017Apr 30, 2017-$1.08M–
Q1 FY2017CQ4 2016Jan 31, 2017-$744.03K–
Q4 FY2016CQ3 2016Oct 31, 2016-$684.87K–

More Anixa Biosciences figures

See a number that looks wrong?